~~<i id='2CAB6739FF'><strike id='2CAB6739FF'><tt id='2CAB6739FF'><pre id='2CAB6739FF'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：knowledge 2025-10-06 11:59:35 Page View：8257

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： McConnell is warmly embraced by Kentucky Republicans amid questions about his health
Next article： Medical leaders decry Supreme Court decision on affirmative action

Wikipedia

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

DarronCummings/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

The stability of $0 premiums in Medicare Advantage

PabloMartinezMonsivais/APYou’rereadingthewebeditionofHealthCareInc.,STAT’sweeklynewsletterfollowingt